Celldex Therapeutics Inc
CLDX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$29.48
Today
-1.4%
YTD
+10.5%
About
With headquarters in Hampton, New Jersey, Celldex operates in the healthcare sector, developing and commercialising cancer-targeting biologics and immunotherapies. The company was established in 1983 and is listed on the NASDAQ CM stock market under the ticker CLDX. For the most recent news on CLDX share price changes, make this instrument an addition to your eToro watchlist.
Price chart
Closing price history for CLDX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-7.48
P/S (TTM)16055.73
P/B (TTM)3.58
Market cap$2.56B
Cap tierMid-cap
Industry avg P/E-2.18
Profitability
Gross margin-2049.37%
EBIT margin-206220.25%
Net margin-334104.55%
ROE-43.88%
ROA-40.76%
Earnings & Revenue
Revenue (TTM)$158,000.00
Revenue growth (1Y)-97.3%
EPS (TTM)-$4.36
Free cash flow$-242.10M
Total debt$4.90M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.14
Employees198
Next earnings9 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.